GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 204 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2022. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $127,000 | +225.6% | 11,100 | +793.7% | 0.01% | +200.0% |
| Q2 2022 | $39,000 | -93.7% | 1,242 | -94.6% | 0.00% | -90.9% |
| Q1 2022 | $618,000 | +3152.6% | 22,937 | +94.4% | 0.03% | – |
| Q4 2021 | $19,000 | -40.6% | 11,800 | +162.2% | 0.00% | -100.0% |
| Q3 2021 | $32,000 | -22.0% | 4,500 | +100.4% | 0.00% | -50.0% |
| Q2 2021 | $41,000 | -64.0% | 2,245 | -80.1% | 0.00% | -60.0% |
| Q1 2021 | $114,000 | -51.9% | 11,300 | -39.6% | 0.01% | -54.5% |
| Q4 2020 | $237,000 | +0.4% | 18,715 | +14.8% | 0.01% | -21.4% |
| Q3 2020 | $236,000 | +713.8% | 16,300 | +101.2% | 0.01% | +600.0% |
| Q2 2020 | $29,000 | -48.2% | 8,100 | -12.9% | 0.00% | -33.3% |
| Q1 2020 | $56,000 | -81.0% | 9,300 | -53.3% | 0.00% | -83.3% |
| Q4 2019 | $294,000 | +124.4% | 19,900 | +192.6% | 0.02% | +63.6% |
| Q3 2019 | $131,000 | -55.1% | 6,800 | -82.9% | 0.01% | -59.3% |
| Q2 2019 | $292,000 | +311.3% | 39,800 | +867.7% | 0.03% | +350.0% |
| Q1 2019 | $71,000 | -84.8% | 4,113 | -90.0% | 0.01% | -86.7% |
| Q4 2018 | $468,000 | -17.8% | 41,053 | -10.9% | 0.04% | +15.4% |
| Q3 2018 | $569,000 | -2.7% | 46,100 | -18.5% | 0.04% | -15.2% |
| Q2 2018 | $585,000 | +79.4% | 56,533 | +46.5% | 0.05% | +64.3% |
| Q1 2018 | $326,000 | -73.7% | 38,600 | -53.1% | 0.03% | -45.1% |
| Q4 2017 | $1,241,000 | +3445.7% | 82,284 | +1474.2% | 0.05% | +5000.0% |
| Q3 2017 | $35,000 | -87.9% | 5,227 | -90.0% | 0.00% | -90.0% |
| Q2 2017 | $290,000 | -68.2% | 52,161 | -43.9% | 0.01% | -73.7% |
| Q1 2017 | $912,000 | +1420.0% | 92,985 | +254.1% | 0.04% | +1166.7% |
| Q4 2016 | $60,000 | -70.6% | 26,256 | -48.7% | 0.00% | -66.7% |
| Q3 2016 | $204,000 | +325.0% | 51,200 | +216.0% | 0.01% | +350.0% |
| Q2 2016 | $48,000 | -34.2% | 16,200 | +50.0% | 0.00% | -60.0% |
| Q1 2016 | $73,000 | – | 10,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 177,414 | $14,103,000 | 11.50% |
| Fernwood Investment Management, LLC | 258,012 | $20,509,000 | 9.81% |
| Perceptive Advisors | 5,865,726 | $466,266,000 | 9.26% |
| ArchPoint Investors | 186,756 | $14,845,000 | 4.54% |
| STANSBERRY ASSET MANAGEMENT, LLC | 115,638 | $9,192,000 | 3.74% |
| Camber Capital Management LP | 730,000 | $58,028,000 | 2.95% |
| Profit Investment Management, LLC | 46,873 | $3,726,000 | 2.50% |
| Casdin Capital, LLC | 300,000 | $23,847,000 | 2.19% |
| SECTORAL ASSET MANAGEMENT INC | 174,594 | $13,878,000 | 2.07% |
| Corriente Advisors, LLC | 40,000 | $3,180,000 | 1.71% |